151 related articles for article (PubMed ID: 27395016)
1. Pironetin Binds Covalently to αCys316 and Perturbs a Major Loop and Helix of α-Tubulin to Inhibit Microtubule Formation.
Prota AE; Setter J; Waight AB; Bargsten K; Murga J; Diaz JF; Steinmetz MO
J Mol Biol; 2016 Jul; 428(15):2981-8. PubMed ID: 27395016
[TBL] [Abstract][Full Text] [Related]
2. Pironetin reacts covalently with cysteine-316 of α-tubulin to destabilize microtubule.
Yang J; Wang Y; Wang T; Jiang J; Botting CH; Liu H; Chen Q; Yang J; Naismith JH; Zhu X; Chen L
Nat Commun; 2016 Jun; 7():12103. PubMed ID: 27357539
[TBL] [Abstract][Full Text] [Related]
3. The anticancer natural product pironetin selectively targets Lys352 of alpha-tubulin.
Usui T; Watanabe H; Nakayama H; Tada Y; Kanoh N; Kondoh M; Asao T; Takio K; Watanabe H; Nishikawa K; Kitahara T; Osada H
Chem Biol; 2004 Jun; 11(6):799-806. PubMed ID: 15217613
[TBL] [Abstract][Full Text] [Related]
4. Revisiting microtubule targeting agents: α-Tubulin and the pironetin binding site as unexplored targets for cancer therapeutics.
Coulup SK; Georg GI
Bioorg Med Chem Lett; 2019 Aug; 29(15):1865-1873. PubMed ID: 31130264
[TBL] [Abstract][Full Text] [Related]
5. Molecular Docking of Cryptoconcatones to α-Tubulin and Related Pironetin Analogues.
Vergoten G; Bailly C
Plants (Basel); 2023 Jan; 12(2):. PubMed ID: 36679009
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis induction via microtubule disassembly by an antitumour compound, pironetin.
Kondoh M; Usui T; Nishikiori T; Mayumi T; Osada H
Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):411-6. PubMed ID: 10333483
[TBL] [Abstract][Full Text] [Related]
7. Studies of (-)-pironetin binding to α-tubulin: conformation, docking, and molecular dynamics.
Bañuelos-Hernández AE; Mendoza-Espinoza JA; Pereda-Miranda R; Cerda-García-Rojas CM
J Org Chem; 2014 May; 79(9):3752-64. PubMed ID: 24761989
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of pironetin analogues with simplified structure and study of their interactions with microtubules.
Marco JA; García-Pla J; Carda M; Murga J; Falomir E; Trigili C; Notararigo S; Díaz JF; Barasoain I
Eur J Med Chem; 2011 May; 46(5):1630-7. PubMed ID: 21396747
[TBL] [Abstract][Full Text] [Related]
9. The Mechanism of the Interactions of Pironetin Analog/Combretastatin A-4 Hybrids with Tubulin.
Torijano-Gutiérrez S; Vilanova C; Díaz-Oltra S; Murga J; Falomir E; Carda M; Redondo-Horcajo M; Díaz JF; Barasoain I; Marco JA
Arch Pharm (Weinheim); 2015 Aug; 348(8):541-7. PubMed ID: 26085125
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of C2 functionalized analogs of the α-tubulin-binding natural product pironetin.
Huang DS; Wong HL; Georg GI
Bioorg Med Chem Lett; 2018 Sep; 28(16):2789-2793. PubMed ID: 29138028
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of pironetin analogue/colchicine hybrids and study of their cytotoxic activity and mechanisms of interaction with tubulin.
Vilanova C; Díaz-Oltra S; Murga J; Falomir E; Carda M; Redondo-Horcajo M; Díaz JF; Barasoain I; Marco JA
J Med Chem; 2014 Dec; 57(24):10391-403. PubMed ID: 25426924
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of simplified pironetin analogues with modifications in the side chain and the lactone ring.
Roldán S; Cardona A; Conesa L; Murga J; Falomir E; Carda M; Marco JA
Org Biomol Chem; 2016 Dec; 15(1):220-232. PubMed ID: 27901163
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of action of microtubule-stabilizing anticancer agents.
Prota AE; Bargsten K; Zurwerra D; Field JJ; Díaz JF; Altmann KH; Steinmetz MO
Science; 2013 Feb; 339(6119):587-90. PubMed ID: 23287720
[TBL] [Abstract][Full Text] [Related]
14. Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site.
Matthew S; Chen QY; Ratnayake R; Fermaintt CS; Lucena-Agell D; Bonato F; Prota AE; Lim ST; Wang X; Díaz JF; Risinger AL; Paul VJ; Oliva MÁ; Luesch H
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619102
[TBL] [Abstract][Full Text] [Related]
15. A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs.
Prota AE; Bargsten K; Diaz JF; Marsh M; Cuevas C; Liniger M; Neuhaus C; Andreu JM; Altmann KH; Steinmetz MO
Proc Natl Acad Sci U S A; 2014 Sep; 111(38):13817-21. PubMed ID: 25114240
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of truncated α-tubulin-binding pironetin analogues lacking alkyl pendants in the side chain or the dihydropyrone ring.
Paños J; Díaz-Oltra S; Sánchez-Peris M; García-Pla J; Murga J; Falomir E; Carda M; Redondo-Horcajo M; Díaz JF; Barasoain I; Marco JA
Org Biomol Chem; 2013 Sep; 11(35):5809-26. PubMed ID: 23892508
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of microtubule assembly by a complex of actin and antitumor macrolide aplyronine A.
Kita M; Hirayama Y; Yoneda K; Yamagishi K; Chinen T; Usui T; Sumiya E; Uesugi M; Kigoshi H
J Am Chem Soc; 2013 Dec; 135(48):18089-95. PubMed ID: 24228690
[TBL] [Abstract][Full Text] [Related]
18. Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites.
Buey RM; Calvo E; Barasoain I; Pineda O; Edler MC; Matesanz R; Cerezo G; Vanderwal CD; Day BW; Sorensen EJ; López JA; Andreu JM; Hamel E; Díaz JF
Nat Chem Biol; 2007 Feb; 3(2):117-25. PubMed ID: 17206139
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferating activity of the mitotic inhibitor pironetin against vindesine- and paclitaxel-resistant human small cell lung cancer H69 cells.
Yoshida M; Matsui Y; Ikarashi Y; Usui T; Osada H; Wakasugi H
Anticancer Res; 2007; 27(2):729-36. PubMed ID: 17465195
[TBL] [Abstract][Full Text] [Related]
20. Suppression of microtubule dynamics by binding of cemadotin to tubulin: possible mechanism for its antitumor action.
Jordan MA; Walker D; de Arruda M; Barlozzari T; Panda D
Biochemistry; 1998 Dec; 37(50):17571-8. PubMed ID: 9860873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]